Company / Tangible Book Value per Share
SELLAS Life Sciences Group, Inc. Tangible Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.12
FY2024
5-year range
-$0.47 / $5.13
FY2020-FY2024
Trend
+126.2%
vs FY2023
Sector context
#179 of 209
Health Care
What the data says
SELLAS Life Sciences Group, Inc.'s tangible book value per share of $0.12 is lower than 86% of companies in the Health Care sector (FY2024). Tangible Book Value per Share returned to growth in FY2024 after 3 years of decline, reaching $0.12.
Based on SEC 10-K filings.
0.12 in FY2024 with a 5-year CAGR of -40.3%.
Declined from $1.16 to $0.12 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -59.3%
- 5-Year CAGR
- -40.3%
- 10-Year CAGR
- -
Sector benchmark
-99.9% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 126.2% year-over-year.
- Ranks #179 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.12 | +126.2% |
| FY2023 | -$0.47 | -140.6% |
| FY2022 | $1.16 | -36.5% |
| FY2021 | $1.83 | -64.4% |
| FY2020 | $5.13 | +213.9% |
| FY2019 | $1.63 | -87.2% |
| FY2018 | $12.74 | +19007.0% |
| FY2017 | $0.07 | +105.0% |
| FY2016 | -$1.35 | -711.0% |
| FY2015 | -$0.17 | -158.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026